Japanese encephalitis virus infection

Handbook of Clinical Neurology

Volumn 123, Issue , 2014, Pages 561-576

  Griffiths, Michael J ^a,b   Turtle, Lance ^a   Solomon, Tom ^a,c,d  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^c THE WALTON CENTRE NHS FOUNDATION TRUST   (United Kingdom)

^d NIHR Health Protection Research Unit in Emerging and Zoonotic Infections   (United Kingdom)

Author keywords

Asia; Brain damage; Disability; Flavivirus; Global; Japanese encephalitis; Vaccine

Indexed keywords

VACCINE;

ANIMAL; ARTICLE; ASIA; BRAIN DAMAGE; DISABILITY; DISEASE TRANSMISSION; FLAVIVIRUS; GLOBAL; HUMAN; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; PATHOGENICITY;

ASIA; BRAIN DAMAGE; DISABILITY; FLAVIVIRUS; GLOBAL; JAPANESE ENCEPHALITIS; VACCINE;

ANIMALS; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; HUMANS;

EID: 84903954223     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53488-0.00026-2     Document Type: Chapter

References (138)

1. Abe M., Okada K., Hayashida K., et al. Duration of neutralizing antibody titer after Japanese encephalitis vaccination. Microbiol Immunol 2007, 51:609-616.
2. Anonymous Japanese encephalitis in two children, United States, 2010. MMWR Morb Mortal Wkly Rep 2011, 60:276-278.
3. Barkhash A.V., Perelygin A.A., Babenko V.N., et al. Variability in the 2'-5'-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease. J Infect Dis 2010, 202:1813-1818.
4. Beasley D.W., Li L., Suderman M.T., et al. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine. Vaccine 2004, 22:3722-3726.
5. Beasley D.W., Lewthwaite P., Solomon T. Current use and development of vaccines for Japanese encephalitis. Expert Opin Biol Ther 2008, 8:95-106.
6. Bi P., Zhang Y., Parton K.A. Weather variables and Japanese encephalitis in the metropolitan area of Jinan city, China. J Infect 2007, 55:551-556.
7. Bista M.B., Banerjee M.K., Shin S.H., et al. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet 2001, 358:791-795.
8. Biswas S.M., Ayachit V.M., Sapkal G.N., et al. Japanese encephalitis virus produces a CD4+ Th2 response and associated immunoprotection in an adoptive-transfer murine model. J Gen Virol 2009, 90:818-826.
9. Burke D.S., Lorsomrudee W., Leake C.J., et al. Fatal outcome in Japanese encephalitis. Am J Trop Med Hyg 1985, 34:1203-1210.
10. Burke D.S., Nisalak A., Ussery M.A., et al. Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis 1985, 151:1093-1099.
11. Campbell G.L., Hills S.L., Fischer M., et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ 2011, 89:766-774. 774A-774E.
12. CDC Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practises (ACIP). MMWR Recomm Rep 1993, 42 (RR-1):1-14.
13. Chua K.B., Goh K.J., Wong K.T., et al. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet 1999, 354:1257-1259.
14. Chunsuttiwat S. Japanese encephalitis in Thailand. Southeast Asian J Trop Med Public Health 1989, 20:593-597.
15. Das S., Dutta K., Kumawat K.L., et al. Abrogated inflammatory response promotes neurogenesis in a murine model of Japanese encephalitis. PLoS One 2011, 6:e17225.
16. Davidson M.M., Williams H., Macleod J.A. Louping ill in man: a forgotten disease. J Infect 1991, 23:241-249.
17. Desai A., Shankar S.K., Ravi V., et al. Japanese encephalitis virus antigen in the human brain and its topographic distribution. Acta Neuropathol 1995, 89:368-373.
18. Desai A., Shankar S.K., Jayakumar P.N., et al. Co-existence of cerebral cysticercosis with Japanese encephalitis: a prognostic modulator. Epidemiol Infect 1997, 118:165-171.
19. Dickerson R.B., Newton J.R., Hansen J.E. Diagnosis and immediate prognosis of Japanese B encephalitis; observations based on more than 200 patients with detailed analysis of 65 serologically confirmed cases. Am J Med 1952, 12:277-288.
20. Dropulic B., Masters C.L. Entry of neurotropic arboviruses into the central nervous system: an in vitro study using mouse brain endothelium. J Infect Dis 1990, 161:685-691.
21. Dung N.M., Turtle L., Chong W.K., et al. An evaluation of the usefulness of neuroimaging for the diagnosis of Japanese encephalitis. J Neurol 2009, 256:2052-2060.
22. Ferguson M., Kurane I., Wimalaratne O., et al. WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1-2 June 2006. Vaccine 2007, 25:5233-5243.
23. Gatchalian S., Yao Y., Zhou B., et al. Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants. Vaccine 2008, 26:2234-2241.
24. German A.C., Myint K.S., Mai N.T., et al. A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model. Trans R Soc Trop Med Hyg 2006, 100:1135-1145.
25. Gould E.A., Zanotto P.M., Holmes E.C. The genetic evolution of flaviviruses. Factors in the emergence of arbovirus diseases 1997, 51-63. Elsevier, Paris. J.F. Saluzzo, B. Dodet (Eds.).
26. Griffiths M.J., Lemon J.V., Rayamajhi A., et al. The functional, social and economic impact of acute encephalitis syndrome in Nepal - a longitudinal follow-up study. PLoS Negl Trop Dis 2013, 7:e2383.
27. Halstead S.B., Grosz C.R. Subclinical Japanese encephalitis. I. Infection of Americans with limited residence in Korea. Am J Hyg 1962, 75:190-201.
28. Hanna J.N., Ritchie S.A., Phillips D.A., et al. An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust 1996, 165:256-260.
29. Hanna J.N., Ritchie S.A., Phillips D.A., et al. Japanese encephalitis in north Queensland, Australia, 1998. Med J Aust 1999, 170:533-536.
30. Hanna J.N., Smith G.A., Mcculloch B.G., et al. An assessment of the interval between booster doses of Japanese encephalitis vaccine in the Torres Strait. Aust N Z J Public Health 2005, 29:44-47.
31. Hasegawa H., Yoshida M., Fujita S., et al. Comparison of structural proteins among antigenically different Japanese encephalitis virus strains. Vaccine 1994, 12:841-844.
32. Haymaker W., Sabin A.B. Topographic distribution of lesions in central nervous system in Japanese B encephalitis; nature of the lesions, with report of a case on Okinawa. Arch Neurol Psychiatry 1947, 57:673-692.
33. Hennessy S., Liu Z., Tsai T.F., et al. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study. Lancet 1996, 347:1583-1586.
34. Higgs S., Gould E.A. Differences in fusogenicity and mouse neurovirulence of Japanese encephalitis viruses. Arch Virol 1991, 119:119-133.
35. Hills S.L., Van Cuong N., Touch S., et al. Disability from Japanese encephalitis in Cambodia and Viet Nam. J Trop Pediatr 2011, 57:241-244.
36. Hoke C.H., Nisalak A., Sangawhipa N., et al. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 1988, 319:608-614.
37. Hoke C.H., Vaughn D.W., Nisalak A., et al. Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus. J Infect Dis 1992, 165:631-637.
38. Hsu S.M., Yen A.M., Chen T.H. The impact of climate on Japanese encephalitis. Epidemiol Infect 2008, 136:980-987.
39. Huang C.H. Studies of Japanese encephalitis in China. Adv Virus Res 1982, 27:71-101.
40. Huy B.V., Tu H.C., Luan T.V., et al. Early mental and neurological sequelae after Japanese B encephalitis. Southeast Asian J Trop Med Public Health 1994, 25:549-553.
41. Igarashi A., Tanaka M., Morita K., et al. Detection of West Nile and Japanese encephalitis viral genome sequences in cerebrospinal fluid from acute encephalitis cases in Karachi, Pakistan. Microbiol Immunol 1994, 38:827-830.
42. Impoinvil D.E., Solomon T., Schluter W.W., et al. The spatial heterogeneity between Japanese encephalitis incidence distribution and environmental variables in Nepal. PLoS One 2011, 6:e22192.
43. Innis B.L. Japanese encephalitis. Exotic viral infections 1995, Chapman & Hall, London. J.S. Porterfield (Ed.).
44. Johnson R.T., Burke D.S., Elwell M., et al. Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol 1985, 18:567-573.
45. Kalita J., Misra U.K. EEG in Japanese encephalitis: a clinico-radiological correlation. Electroencephalogr Clin Neurophysiol 1998, 106:238-243.
46. Kalita J., Misra U.K., Pandey S., et al. A comparison of clinical and radiological findings in adults and children with Japanese encephalitis. Arch Neurol 2003, 60:1760-1764.
47. Kedarnath N., Prasad S.R., Dandawate C.N., et al. Isolation of Japanese encephalitis & West Nile viruses from peripheral blood of encephalitis patients. Indian J Med Res 1984, 79:1-7.
48. Kimura K., Dosaka A., Hashimoto Y., et al. Single-photon emission CT findings in acute Japanese encephalitis. AJNR Am J Neuroradiol 1997, 18:465-469.
49. Kimura-Kuroda J., Yasui K. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J Immunol 1988, 141:3606-3610.
50. Klein R.S., Lin E., Zhang B., et al. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol 2005, 79:11457-11466.
51. Konishi E., Kurane I., Mason P.W., et al. Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes. Am J Trop Med Hyg 1995, 53:278-283.
52. Kumar R., Mathur A., Kumar A., et al. Clinical features & prognostic indicators of Japanese encephalitis in children in Lucknow (India). Indian J Med Res 1990, 91:321-327.
53. Kumar R., Agarwal S.P., Wakhlu I., et al. Japanese encephalitis - an encephalomyelitis. Indian Pediatr 1991, 28:1525-1528.
54. Kumar R., Mathur A., Singh K.B., et al. Clinical sequelae of Japanese encephalitis in children. Indian J Med Res 1993, 97:9-13.
55. Kumar S., Misra U.K., Kalita J, et al. MRI in Japanese encephalitis. Neuroradiology 1997, 39:180-184.
56. Kumar P., Uchil P.D., Sulochana P., et al. Screening for T cell-eliciting proteins of Japanese encephalitis virus in a healthy JE-endemic human cohort using recombinant baculovirus-infected insect cell preparations. Arch Virol 2003, 148:1569-1591.
57. Kumar P., Krishna V.D., Sulochana P., et al. Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain. J Gen Virol 2004, 85:471-482.
58. Kumar P., Sulochana P., Nirmala G., et al. Impaired T helper 1 function of nonstructural protein 3-specific T cells in Japanese patients with encephalitis with neurological sequelae. J Infect Dis 2004, 189:880-891.
59. Kumar P., Sulochana P., Nirmala G., et al. Conserved amino acids 193-324 of non-structural protein 3 are a dominant source of peptide determinants for CD4+ and CD8+ T cells in a healthy Japanese encephalitis virus-endemic cohort. J Gen Virol 2004, 85:1131-1143.
60. Kumar R., Tripathi P., Baranwal M., et al. Randomized, controlled trial of oral ribavirin for Japanese encephalitis in children in Uttar Pradesh, India. Clin Infect Dis 2009, 48:400-406.
61. Kumar R., Tripathi P., Rizvi A. Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis. N Engl J Med 2009, 360:1465-1466.
62. Larena M., Regner M., Lee E., et al. Pivotal role of antibody and subsidiary contribution of CD8+ T cells to recovery from infection in a murine model of Japanese encephalitis. J Virol 2011, 85:5446-5455.
63. Leake C.J., Burke D.S., Nisalak A., et al. Isolation of Japanese encephalitis virus from clinical specimens using a continuous mosquito cell line. Am J Trop Med Hyg 1986, 35:1045-1050.
64. Lewthwaite P., Begum A., Ooi M.H., et al. Disability after encephalitis: development and validation of a new outcome score. Bull World Health Organ 2010, 88:584-592.
65. Lewthwaite P., Shankar M.V., Tio P.H., et al. Evaluation of two commercially available ELISAs for the diagnosis of Japanese encephalitis applied to field samples. Trop Med Int Health 2010, 15:811-818.
66. Li Z.S., Hong S.F., Gong N.L. Immunohistochemical study on Japanese B encephalitis. Chin Med J (Engl) 1988, 101:768-771.
67. Li J.K., Liang J.J., Liao C.L., et al. Autophagy is involved in the early step of Japanese encephalitis virus infection. Microbes Infect 2012, 14:159-168.
68. Libraty D.H., Nisalak A., Endy T.P., et al. Clinical and immunological risk factors for severe disease in Japanese encephalitis. Trans R Soc Trop Med Hyg 2002, 96:173-178.
69. Lim J.K., Lisco A., Mcdermott D.H., et al. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog 2009, 5:e1000321.
70. Lindenbach B.D., Pragai B.M., Montserret R., et al. The C terminus of hepatitis C virus NS4A encodes an electrostatic switch that regulates NS5A hyperphosphorylation and viral replication. J Virol 2007, 81:8905-8918.
71. Liou M.L., Hsu C.Y. Japanese encephalitis virus is transported across the cerebral blood vessels by endocytosis in mouse brain. Cell Tissue Res 1998, 293:389-394.
72. Liu Z.L., Hennessy S., Strom B.L., et al. Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects. J Infect Dis 1997, 176:1366-1369.
73. Mathers C.D., Ezzati M., Lopez A.D. Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis 2007, 1:e114.
74. McMinn P.C. The molecular basis of virulence of the encephalitogenic flaviviruses. J Gen Virol 1997, 78:2711-2722.
75. Mishra M.K., Basu A. Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis. J Neurochem 2008, 105:1582-1595.
76. Misra U.K., Kalita J. Movement disorders in Japanese encephalitis. J Neurol 1997, 244:299-303.
77. Misra U.K., Kalita J. A comparative study of Japanese and herpes simplex encephalitides. Electromyogr Clin Neurophysiol 1998, 38:41-46.
78. Misra U.K., Kalita J., Jain S.K., et al. Radiological and neurophysiological changes in Japanese encephalitis. J Neurol Neurosurg Psychiatry 1994, 57:1484-1487.
79. Miyake M. The pathology of Japanese encephalitis. A review. Bull World Health Organ 1964, 30:153-160.
80. Mogi M. Relationship between number of human Japanese encephalitis cases and summer meteorological conditions in Nagasaki, Japan. Am J Trop Med Hyg 1983, 32:170-174.
81. Monath T.P., Cropp C.B., Harrison A.K. Mode of entry of a neurotropic arbovirus into the central nervous system. Reinvestigation of an old controversy. Lab Invest 1983, 48(4):399-410.
82. Monath T.P., Guirakhoo F., Nichols R., et al. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. J Infect Dis 2003, 188(8):1213-1230.
83. Murty U.S., Rao M.S., Arunachalam N The effects of climatic factors on the distribution and abundance of Japanese encephalitis vectors in Kurnool district of Andhra Pradesh, India. J Vector Borne Dis 2010, 47:26-32.
84. Myint K.S., Raengsakulrach B., Young G.D., et al. Production of lethal infection that resembles fatal human disease by intranasal inoculation of macaques with Japanese encephalitis virus. Am J Trop Med Hyg 1999, 60:338-342.
85. Nathanson N., Cole G.A. Fatal Japanese encephalitis virus infection in immunosuppressed spider monkeys. Clin Exp Immunol 1970, 6:161-166.
86. Nazmi A., Dutta K., Das S, et al. Japanese encephalitis virus-infected macrophages induce neuronal death. J Neuroimmune Pharmacol 2011, 6:420-433.
87. Ni H., Barrett A.D. Molecular differences between wild-type Japanese encephalitis virus strains of high and low mouse neuroinvasiveness. J Gen Virol 1996, 77:1449-1455.
88. Ohrr H., Tandan J.B., Sohn Y.M., et al. Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study. Lancet 2005, 366:1375-1378.
89. Olsen S.J., Supawat K., Campbell A.P., et al. Japanese encephalitis virus remains an important cause of encephalitis in Thailand. Int J Infect Dis 2010, 14:e888-e892.
90. Olson J.G., Atmosoedjono S., Lee V.H., et al. Correlation between population indices of Culex tritaeniorhynchus and Cx. gelidus (Diptera: Culicidae) and rainfall in Kapuk, Indonesia. J Med Entomol 1983, 20:108-109.
91. Ooi M.H., Lewthwaite P., Lai B.F., et al. The epidemiology, clinical features, and long-term prognosis of Japanese encephalitis in central Sarawak, Malaysia, 1997-2005. Clin Infect Dis 2008, 47:458-468.
92. Poneprasert B. Japanese encephalitis in children in northern Thailand. Southeast Asian J Trop Med Public Health 1989, 20:599-603.
93. Pyke A.T., Williams D.T., Nisbet D.J., et al. The appearance of a second genotype of Japanese encephalitis virus in the Australasian region. Am J Trop Med Hyg 2001, 65:747-753.
94. Pyrgos V., Younus F. High-dose steroids in the management of acute flaccid paralysis due to West Nile virus infection. Scand J Infect Dis 2004, 36:509-512.
95. Ravi V., Desai A., Balaji M., et al. Development and evaluation of a rapid IgM capture ELISA (JEV-Chex) for the diagnosis of Japanese encephalitis. J Clin Virol 2006, 35:429-434.
96. Ravi V., Robinson J.S., Russell B.J., et al. Evaluation of IgM antibody capture enzyme-linked immunosorbent assay kits for detection of IgM against Japanese encephalitis virus in cerebrospinal fluid samples. Am J Trop Med Hyg 2009, 81:1144-1150.
97. Rayamajhi A., Ansari I., Ledger E., et al. Clinical and prognostic features among children with acute encephalitis syndrome in Nepal; a retrospective study. BMC Infect Dis 2011, 11:294.
98. Reisen W.K., Aslamkhan M., Basio R.G. The effects of climatic patterns and agricultural practices on the population dynamics of Culex tritaeniorhynchus in Asia. Southeast Asian J Trop Med Public Health 1976, 61-71.
99. Richter R.W., Shimojyo S. Neurologic sequelae of Japanese B encephalitis. Neurology 1961, 11:553-559.
100. Sapkal G.N., Wairagkar N.S., Ayachit V.M., et al. Detection and isolation of Japanese encephalitis virus from blood clots collected during the acute phase of infection. Am J Trop Med Hyg 2007, 77:1139-1145.
101. Schneider R.J., Firestone M.H., Edelman R., et al. Clinical sequelae after Japanese encephalitis: a one year follow-up study in Thailand. Southeast Asian J Trop Med Public Health 1974, 5:560-568.
102. Shoji H., Hiraki Y., Kuwasaki N., et al. Japanese encephalitis in the Kurume region of Japan: CT and MRI findings. J Neurol 1989, 236:255-259.
103. Shoji H., Murakami T., Murai I., et al. A follow-up study by CT and MRI in 3 cases of Japanese encephalitis. Neuroradiology 1990, 32:215-219.
104. Shoji H., Kida H., Hino H., et al. Magnetic resonance imaging findings in Japanese encephalitis. White matter lesions. J Neuroimaging 1994, 4:206-211.
105. Shrestha B., Diamond M.S. Role of CD8+ T cells in control of West Nile virus infection. J Virol 2004, 78:8312-8321.
106. Simpson T.W., Meiklejohn G. Sequelae of Japanese B encephalitis. Am J Trop Med Hyg 1947, 27:727-731.
107. Solomon T. Encephalitis. Lecture Notes: Tropical Medicine 2004, Blackwell Scientific, Oxford. 5th edn. G.V. Gill, N.J. Beeching (Eds.).
108. Solomon T. New vaccines for Japanese encephalitis. Lancet Neurol 2008, 7:116-118.
109. Solomon T., Vaughn D.W. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Microbiol Immunol 2002, 267:171-194.
110. Solomon T., Winter P.M. Neurovirulence and host factors in flavivirus encephalitis - evidence from clinical epidemiology. Emergence and control of zoonotic viral encephalitides 2004, 161-170. Springer, New York. C.H. Calisher, D.H. Griffin (Eds.).
111. Solomon T., Kneen R., Dung N.M., et al. Poliomyelitis-like illness due to Japanese encephalitis virus. Lancet 1998, 351:1094-1097.
112. Solomon T., Thao L.T., Dung N.M., et al. Rapid diagnosis of Japanese encephalitis by using an immunoglobulin M dot enzyme immunoassay. J Clin Microbiol 1998, 36:2030-2034.
113. Solomon T., Dung N.M., Kneen R., et al. Japanese encephalitis. J Neurol Neurosurg Psychiatry 2000, 68:405-415.
114. Solomon T., Dung N.M., Kneen R., et al. Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain 2002, 125:1084-1093.
115. Solomon T., Dung N.M., Wills B., et al. Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet 2003, 361:821-826.
116. Swami R., Ratho R.K., Mishra B., et al. Usefulness of RT-PCR for the diagnosis of Japanese encephalitis in clinical samples. Scand J Infect Dis 2008, 40:815-820.
117. Takahashi M. The effects of environmental and physiological conditions of Culex tritaeniorhynchus on the pattern of transmission of Japanese encephalitis virus. J Med Entomol 1976, 13:275-284.
118. Tandan J.B., Ohrr H., Sohn Y.M., et al. Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. Vaccine 2007, 25:5041-5045.
119. Tauber E., Kollaritsch H., Korinek M., et al. Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial. Lancet 2007, 370:1847-1853.
120. Tiroumourougane S.V., Raghava P., Srinivasana S., et al. Management parameters affecting the outcome of Japanese encephalitis. J Trop Pediatr 2003, 49:153-156.
121. Torresi J., McCarthy K., Feroldi E., et al. Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials. Vaccine 2010, 28:7993-8000.
122. Tseng Y.F., Wang C.C., Liao S.K., et al. Autoimmunity-related demyelination in infection by Japanese encephalitis virus. J Biomed Sci 2011, 18:20.
123. Turtle L., Griffiths M.J., Solomon T. Encephalitis caused by flaviviruses. QJM 2012, 105:219-223.
124. Tzeng S.S. Respiratory paralysis as a presenting symptom in Japanese encephalitis-a case report. Zhonghua Yi Xue Za Zhi (Taipei) 1989, 43(3):208-212.
125. Vaughn D.W., Hoke C.H. The epidemiology of Japanese encephalitis: prospects for prevention. Epidemiol Rev 1992, 14:197-221.
126. Wang K., Deubel V. Mice with different susceptibility to Japanese encephalitis virus infection show selective neutralizing antibody response and myeloid cell infectivity. PLoS One 2011, 6:e24744.
127. Wang Y., Lobigs M., Lee E., et al. CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol 2003, 77:13323-13334.
128. WHO Global Advisory Committee on Vaccine Safety. Wkly Epidemiol Rec 2005, 80:242-247.
129. WHO Japanese encephalitis vaccines. Wkly Epidemiol Rec 2006, 81:331-340.
130. WHO Global Advisory Committee on Vaccine Safety. Wkly Epidemiol Rec 2007, 82:18-24.
131. Winter P.M., Dung N.M., Loan H.T., et al. Proinflammatory cytokines and chemokines in humans with Japanese encephalitis. J Infect Dis 2004, 190:1618-1626.
132. Wuryadi S., Suroso T. Japanese encephalitis in Indonesia. Southeast Asian J Trop Med Public Health 1989, 20:575-580.
133. Xin Y.Y., Ming Z.G., Peng G.Y., et al. Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. Am J Trop Med Hyg 1988, 39:214-217.
134. Zhang M.J., Wang M.J., Jiang S.Z., et al. Passive protection of mice, goats, and monkeys against Japanese encephalitis with monoclonal antibodies. J Med Virol 1989, 29:133-138.
135. Zhang B., Chan Y.K., Lu B., et al. CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis. J Immunol 2008, 180:2641-2649.
136. Zhang B., Patel J., Croyle M., et al. TNF-alpha-dependent regulation of CXCR3 expression modulates neuronal survival during West Nile virus encephalitis. J Neuroimmunol 2010, 224:28-38.
137. Zimmerman H.M. The pathology of Japanese B encephalitis. Am J Pathol 1946, 22:965-991.
138. Zimmerman M.D., Scott R.M., Vaughn D.W., et al. Short report: an outbreak of Japanese encephalitis in Kathmandu, Nepal. Am J Trop Med Hyg 1997, 57:283-284.